reGenics
Regenics AS is a Norwegian biotechnology company based in Oslo, focused on developing innovative and sustainable wound care products using marine ingredients from the coast of Norway. Their mission is to redefine standards of wound management with natural, marine-based solutions that promote faster healing and reduce waste in aquaculture.
Industries
Nr. of Employees
small (1-50)
reGenics
Patents
Products
Collex
A 3D-printed hydrogel wound dressing that incorporates a purified salmon roe extract and alginate biomaterial, developed for partial-thickness burns and chronic wounds; in late pre-clinical development.
Vernex
A hydrogel wound spray formulation in a bag-on-valve delivery format containing a purified salmon roe extract, intended for partial-thickness burns and chronic wounds; in pre-clinical development.
WoundClear
A novel enzymatic debridement biologic based on a trout-derived LCE fusion protein, intended to facilitate removal of eschar and necrotic tissue in severe wounds; in discovery-stage development.
Collex
A 3D-printed hydrogel wound dressing that incorporates a purified salmon roe extract and alginate biomaterial, developed for partial-thickness burns and chronic wounds; in late pre-clinical development.
Vernex
A hydrogel wound spray formulation in a bag-on-valve delivery format containing a purified salmon roe extract, intended for partial-thickness burns and chronic wounds; in pre-clinical development.
WoundClear
A novel enzymatic debridement biologic based on a trout-derived LCE fusion protein, intended to facilitate removal of eschar and necrotic tissue in severe wounds; in discovery-stage development.
Expertise Areas
- Wound care product development
- Marine-derived biomaterials
- Medical device development and market strategy
- Enzymatic debridement biologics discovery
Key Technologies
- Hydrogel formulation
- Alginate-based biomaterials
- 3D printing for medical dressings
- Bag-on-valve topical spray delivery